§ PHARMACEUTICALS
USD · Pharmaceuticals

LXRX

LEXICON PHARMACEUTICALS INC
USDSector · Pharmaceuticals
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
86 increased/new, 38 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Artal Group S.A.154.7M23.9%+14%
Fidelity Management45.1M0.0%+19%
Siren, L.L.C.44.3M1.9%+14%
Sessa Capital IM, L.P.17.9M0.5%+497%
VANGUARD CAPITAL MANAGEMENT LLC9.5Mn/an/a
Point727.8M0.0%+2651%
◇ AC INTELLIGENCE

Top institutional owners for LXRX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER20.9% · 0 holders
OTHER61.7% · 97 holders
QUALITY / COMPOUNDER10.8% · 3 holders
PASSIVE / INDEX2.0% · 6 holders
DEALER / BANK1.9% · 22 holders
TACTICAL / MACRO1.6% · 3 holders
SYSTEMATIC / QUANT1.1% · 4 holders
INCOME / DEFENSIVE0.0% · 2 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for LXRX in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention LXRX yet.